• Recent
  • Class
  • Inventors
  • Assignees
  • Top Lists
  • Pricing
  • Account
Patents-Review.com
  1. Home
  2. Inventor
  3. B
  4. Bar…
  5. BARGE Alan
🔗 Permalink
Inventor profile of:

Alan BARGE

City:

Macclesfield

Country:

Great Britain (UK)

Published Applications:

4

Last publication date:

2010-05-13

Recent patent applications by BARGE Alan

Alan BARGE from Macclesfield, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2010-05-13
US20100120708A1
Human necessities

Combination therapy comprising ZD6474 and gemcitabine for anti-cancer therapy

#2 | 2006-06-29
US20060142297A1
Human necessities

Combination product of inhibitor of the src family of non-recetpor tyrosine kinases and gemcitabine

#3 | 2006-03-16
US20060058260A1
Human necessities

Combination therapy with gemcitabine and zd6126

#4 | 2006-01-12
US20060009418A1
Human necessities

Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability

InventorID:

3617440 ⎘

  1. Home
  2. Inventor
  3. B
  4. Bar…
  5. BARGE Alan

Some parts © 2022-2026 Patents-Review.com

Browse & Discovery
  • Home
  • Patent Classification
  • Inventor Index
  • Assignee Index
  • Interesting Applications
Search & Tools
  • Basic Search
  • Advanced Search
  • Patent Alerts
  • Top Lists
  • Statistics
Information & Resources
  • About US Patent System
  • Terms & Privacy
  • Pricing
  • Contact
Quick Access
  • Latest Applications
  • Top Inventors 2026
  • Top Assignees 2026
  • Featured Patents
Disclaimer: This website is intended for informational purposes only, and its content is based on public patent records. Please note that some sections of this website have been created or processed using machine learning models. We provide content in good faith but make no guarantees regarding accuracy or completeness. By using this site, you accept any risks and waive claims against us for errors or omissions.